CoChat

Retinoids in liver fibrosis and cancer

Open access
Okuno, Masataka · 2002 · Frontiers in Bioscience

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Abstract

Pathobiological functions and metabolism of retinoids (vitamin A and its derivatives) in liver fibrosis and hepatocellular carcinoma (HCC) are discussed in the present review. Retinoic acid (RA, active metabolite) exacerbates liver fibrosis that is not accompanied by hepatic necroinflammation, in which RA acts directly on hepatic stellate cells (HSCs); RA enhances plasminogen activator/plasmin levels and thereby induces proteolytic activation of latent transforming growth factor-β (TGF-β), a strong fibrogenic cytokine, resulting in enhanced collagen production. We have developed a protease inhibitor, camostat mesilate, that suppresses TGF-β activation and thereby inhibits the transformation of HSCs, leading to reduced matrix production by the cells. The compound is effective not only in preventing but also in reducing hepatic fibrosis in rats when administered orally. HCC is refractory to RA due to its local depletion in the tumors and also due to malfunction of its nuclear receptor, retinoid X receptor-α (RXRα) Oral supplementation of a synthetic retinoid named acyclic retinoid led to the disappearance of serum lectin-reactive α-fetoprotein (AFP-L3) and subsequently suppressed posttherapeutic recurrence of HCC in cirrhotic patients. These results suggest eradication of AFP-L3-producing latent malignant clones from the liver by the retinoid. We propose the concept of "clonal deletion" therapy for cancer chemoprevention, a new category of cancer chemotherapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2741/okuno

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 3

  1. Sporn M.B., Roberts A.B. & Goodman D.S., Raven Press, New York, 597-630 (1994)
  2. Flaumenhaft R., S. Kojima, M. Abe & D.B. Rifkin: Activation of latent transforming growth factor β. In: Advances in pharmacology. Vol 24. Eds: August J.T., Anders M.W. & Murad F., Academic Press, San Diego, 51-76 (1993)
  3. Sporn M.B. & Roberts A.B., Springer-Verlag, Berlin 419- 472 (1990)

Cited by

Metadata

Authors
Okuno, M.
Affiliations
Gifu University (JP)
Corresponding author
Okuno, Masataka
Venue
Frontiers in Bioscience
Publisher
IMR Press
Published
2002
Volume
7
Issue
1-3
Pages
d204
ISSN
  • 1093-4715 (ISSN-L)
  • 1093-9946
OpenAlex
W2149637294
Cited by
53
References
48
Citations by year
2024: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 3 · 2017: 3 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 1 · 2012: 4
FWCI
1.73
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in bioscience (publishedVersion)
  • Frontiers in bioscience (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Ministry of Health, Labour and Welfare
  • Ministry of Education, Science and Technology
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
Keywords
retinoids, vitamin A, liver fibrosis, hepatocellular carcinoma, retinoic acid, hepatic stellate cells, TGF-beta activation, plasminogen activator, camostat mesilate, retinoid X receptor alpha, acyclic retinoid, alpha-fetoprotein, chemoprevention, collagen synthesis
MeSH terms
Animals, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Liver Neoplasms, Retinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.